Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

TYPE OF SARCOMA: Malignant peripheral nerve sheath tumors sporadic or NF1 associated
DRUG: Adriamycin/ifosfamide and Adriamycin/etoposide
ACCRUAL STATUS: Completed

OVERALL STUDY PRINCIPAL INVESTIGATORS:
Brigitte C. Widemann, MD
National Cancer Institute (NCI)

CLINICALTRIALS.GOV IDENTIFIER: NCT00304083

FOR STUDY DETAILS AND ELIGIBILITY CRITERIA: CLINICALTRIALS.GOV

To learn more about this study or to contact the study research staff: